Photo of Giao Q. Phan, MD, FACS

Giao Q. Phan, MD, FACS

Professor of Surgical Oncology
NPI Number:
1861610339
Academic Office Location:
Neag Comprehensive Cancer Center
UConn Health
263 Farmington Avenue
Farmington, CT 06030
Website(s):

Neag Comprehensive Cancer Center

  • Looking for a Physician?

    This faculty member is also
    a practicing physician at UConn Health.

    Learn more >
Education
DegreeInstitutionMajor
BAColumbia University, Columbia CollegeBiochemistry
MDJohns Hopkins University School of MedicineMedicine

Post-Graduate Training
TrainingInstitutionSpecialty
ResidencyOhio State University Medical CenterGeneral Surgery
FellowshipNational Cancer Institute; National Institutes of HealthImmunotherapy and Surgical Oncology
ResidencyWashington University in St. Louis/Barnes-Jewish HospitalGeneral Surgery
FellowshipMoffitt Cancer CenterSurgical Oncology

Awards
Name of Award/HonorAwarding Organization
Team Science Award, Cancer Immunotherapy and Biological Therapy, Society for Immunotherapy of Cancer (SITC) 25th Annual MeetingSociety for Immunotherapy of Cancer (SITC)
Medical Student Teaching Award, Department of SurgeryWashington University
Fellows Award for Research ExcellenceNational Institute of Health
American Society of Clinical Oncology Merit Award "Cancer Regression and Autoimmunity Induced by CTLA-4 Blockade in Patients with Metastatic Melanoma"American Society of Clinical Oncology (ASCO)
American Society of Clinical Oncology Merit Award. "Quality of Life in Patients with Metastatic Renal Cell Cancer Receiving Different Regimens of Interleukin-2: A Randomized Trial"American Society of Clinical Oncology (ASCO)
National Science Foundation Undergraduate Research Fellowship Department of ChemistryColumbia University
  • Melanoma and Skin/Soft Tissue Cancers
  • Thyroid and Parathyroid Diseases
  • Immunotherapy
  • Adoptive Cell Therapy
  • Clinical Trials
Name & DescriptionCategoryRoleTypeScopeStart YearEnd Year
Society of Surgical Oncology - Melanoma Disease Working GroupProfessional/Scientific OrganizationMemberExternalNational2025
Society for Immunotherapy of Cancer: Surgery CommitteeProfessional/Scientific OrganizationMemberExternalNational2025

Journal Articles

Reviews

Title or AbstractTypeSponsor/EventDate/YearLocation
TIL therapy for advanced melanoma: From experimental to standard carePanel Discussion2026Phoenix, Arizona
An unusual PET-avid thyroid nodulePosterEndocrine Society: ENDO2025 Annual Meeting2025San Francisco, California
Tumor-infiltrating lymphocytes (TIL) therapy for metastatic melanoma: A story of innovation, persistence, and collaborationLectureDepartment of Internal Medicine Clinical Research Seminar2025Farmington, Connecticut
What is TIL therapy and its path to FDA approval for metastatic melanoma?LectureSociety of Surgical Oncology2025Webinar
New updates on novel modified tumor-infiltrating lymphocyte therapy in melanomaLectureASCO: American Society of Clinical Oncology2024Chicago, Illinois
Modern melanoma management: Treating locally advanced or metastatic diseaseLectureACS: American College of Surgeons2024San Francisco, California
Follicular Epithelial Dysplasia with RET/PTC1 Rearrangement in Hashimoto’s ThyroiditisPosterAmerican Thyroid Association2024Chicago, Illinois